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Abstract
N-acetyl-aspartyl-glutamate (NAAG) and its hydrolysis product N-acetyl-aspartate (NAA) are among the most important brain 
metabolites. NAA is a marker of neuron integrity and viability, while NAAG modulates glutamate release and may have a role in 
neuroprotection and synaptic plasticity. Investigating on a quantitative basis the role of these metabolites in brain metabolism in 
vivo by magnetic resonance spectroscopy (MRS) is a major challenge since the main signals of NAA and NAAG largely overlap. 
This is a preliminary study in which we evaluated NAA and NAAG changes during a visual stimulation experiment using functional 
MRS. The paradigm used consisted of a rest period (5 min and 20 s), followed by a stimulation period (10 min and 40 s) and 
another rest period (10 min and 40 s). MRS from 17 healthy subjects were acquired at 3T with TR/TE = 2000/288 ms. Spectra 
were averaged over subjects and quantified with LCModel. The main outcomes were that NAA concentration decreased by 
about 20% with the stimulus, while the concentration of NAAG concomitantly increased by about 200%. Such variations fall into 
models for the energy metabolism underlying neuronal activation that point to NAAG as being responsible for the hyperemic 
vascular response that causes the BOLD signal. They also agree with the fact that NAAG and NAA are present in the brain at a 
ratio of about 1:10, and with the fact that the only known metabolic pathway for NAAG synthesis is from NAA and glutamate.
Key words: Proton magnetic resonance spectroscopy; Functional experiments; Brain activation; Brain energy metabolism; 
N-acetyl-aspartate; N-acetyl-aspartyl-glutamate 
Introduction
Correspondence: G. Castellano, Grupo de Neurofísica, Departamento de Raios Cósmicos e Cronologia, UNICAMP/IFGW, 
Rua Sergio Buarque de Holanda, 777, 13083-859 Campinas, SP, Brasil. Fax: +55-19-3521-5512. E-mail: gabriela@ifi.unicamp.br
Received April 19, 2012. Accepted July 30, 2012. Available online August 17, 2012. Published October 5, 2012.
N-acetyl-aspartate (NAA) is one of the molecules pres-
ent at highest concentrations in the central nervous system 
(CNS) (1). Due to its prominent signal in magnetic resonance 
spectra (MRS), NAA has been used as a diagnostic marker 
for many neuropathologies, including Canavan’s disease, 
ischemia and stroke, Alzheimer’s disease, epilepsy, brain 
tumors, multiple sclerosis, traumatic brain injury, and 
schizophrenia. Most of these pathologies, with the excep-
tion of Canavan’s disease, show a decrease of the NAA 
peak in brain MRS. At first, this decrease was thought to 
be an irreversible neuronal loss. However, at present there 
is evidence that the decrease in NAA concentration can 
also be associated with mitochondrial dysfunction, which 
in some cases could be reversible. In the specific case of 
Canavan’s disease, which is a demyelinating disease (2), 
NAA levels in the CNS are increased due to absence of the 
aspartoacylase enzyme, responsible for the metabolization 
of this compound (1). This fact has suggested that high NAA 
levels in the CNS can also have harmful effects.
N-acetyl-aspartyl-glutamate (NAAG) is a neuron-specific 
dipeptide, present at the highest concentration in the brain 
(1). An important confounding factor in NAA-NAAG MRS 
analyses is that the NAAG peak appears as a shoulder of 
the NAA peak. Although NAA is responsible for the largest 
contribution to the MRS peak at 2 ppm, NAAG can con-
tribute by 10 to 20% to this signal, but very frequently the 
entire peak is attributed only to NAA (3,4). This means that 
decreases in this peak, attributed to NAA, associated with 
all the aforementioned neuropathologies, either involve a 
joint decrease in NAA and NAAG levels, or underestimate 
the decrease in NAA levels in cases where NAAG levels 
increase or stay constant (1).
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Indeed, separate measurements of the NAA and NAAG 
contributions by the MRS technique are difficult due to the 
severe overlap of their respective spectra. In order to sepa-
rate these contributions, post-processing methods such as 
LCModel (5), which adjust the measured spectrum using 
a linear combination of isolated metabolite spectra, have 
been used by some investigators (3,6,7). However, the 
efficacy of LCModel in separating these contributions has 
been contested (8). More recently, Edden et al. (9) used a 
MEGA-PRESS pulse sequence to separately measure the 
contribution of these metabolites in a “static” (conventional) 
MRS experiment. Nevertheless, up to now this has been 
the only study reporting this type of measurement.
The aim of the present study was to evaluate NAA and 
NAAG changes during a visual stimulation experiment 
using functional MRS (fMRS). There are only two other 
reports in the literature that have presented significant 
results regarding NAA variations during a brain activation 
task (10,11), and none that has presented results regard-
ing NAAG variations. On the other hand, there are many 
reports of variations in other metabolites and constancy of 
the NAA peak in similar functional experiments (see Ref. 
12). The discrepancy among these results has generated a 
still inconclusive discussion about possible NAA variations 
in experiments of this nature, showing the need for further 
investigation of this subject.
Material and Methods
All data were acquired with a 3.0T Philips Achieva scan-
ner (Philips, The Netherlands) using an 8-channel SENSE 
head coil. The fMRS protocol used single-voxel localization 
with PRESS, TR/TE = 2000/288 ms, 2048 data points, spec-
tral width of 2000 Hz, 8 spectral averages (16 s/spectrum), 
8 phase cycles, and voxel size 2 x 2 x 2 cm3. The visual 
stimulus consisted of a black-white radial checkerboard 
pattern covering the entire visual field and flickering at 8 
Hz, which was programmed using the E-Prime software 
(Psychology Software Tools, USA, http://www.pstnet.com/), 
and was shown to the subjects on a monitor inside the MR 
scanner using the Eloquence system (InVivo, USA, http://
www.invivocorp.com/fmri/eloquence.php). Before running 
the fMRS protocol, three anatomical T2-weighted images 
in the axial, coronal and sagittal views were acquired for 
voxel positioning. This was followed by a functional magnetic 
resonance imaging protocol, consisting of a block design 
(4 rest blocks and 3 stimulus blocks of 10 s each) with the 
same visual stimulus used for the fMRS experiment, to de-
tect the activated area. The activation map was superposed 
on the T2 images, and the MRS voxel was positioned in 
the right hemisphere (in order to avoid contamination with 
cerebral-spinal fluid) on the occipital lobe, in such a way 
as to cover as much as possible the activated area. Next, 
fMRS acquisition was carried out. The fMRS paradigm 
consisted of one rest (off) block (duration of 5 min and 20 
s, consisting of 20 spectra), followed by one stimulus (on) 
block (10 min and 40 s, 40 spectra) and another rest (off) 
block (10 min and 40 s, 40 spectra), for a total scan dura-
tion of 26 min 40 s (100 spectra). 
Seventeen healthy subjects (mean age 28 ± 4 years, 
range 21-39 years, 7 women) participated in the study. The 
project was approved by the Comitê de Ética em Pesquisa 
of Universidade Estadual de Campinas (UNICAMP), and 
all tested subjects gave written informed consent. 
In addition to the subjects’ scans, six scans were also 
performed on a phantom that emulated main metabolite 
concentrations in the brain, in order to supervise the quality 
of our fMRS measurements (Table 1). These scans were 
performed with the same MR parameters and the same 
total scan duration, on the same days the subjects were 
scanned. 
Data processing and analysis
First, the last two spectra of the first off block, and the 
first and last two spectra of the on and second off blocks 
were discarded due to a small asynchronicity between the 
stimulus generator and the scanner. The spectra were then 
phase corrected (frequency correction was not needed since 
the Achieva scanner parameter “frequency stabilization”, 
which performs real-time frequency drift correction during 
the acquisition, was turned on). Next, 18-spectra-averages 
(4 min and 48 s) were obtained for every subject (and 
every phantom acquisition). The averaged spectra were 
quantified and the relative metabolite concentrations (with 
respect to the first off block) were averaged over subjects 
(or phantom acquisitions). We also tested averaging the 
18-spectra-averages over subjects (or phantom acquisi-
Table 1. Metabolite concentrations used in the 
magnetic resonance spectroscopy phantom.
Metabolite Concentration (mM)
NAA 10
Creatinine 8
Choline 3
Lactate 1
Myo-inositol 6
Glutamate 10
Glutamine 5
DSS 2
Na2HPO4 72
NaCOOH 200
NaH2PO4 28
Sodium azide 1.54
Total volume 0.3 L
NAA = N-acetyl-aspartate; DSS = dimethyl-sila-
pentane-sulfonate; NaCOOH = sodium formate. 
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tions), and then quantifying the resulting all-subjects’ (or 
all-phantoms’) spectra.
All spectra were quantified with LCModel (5). The 
LCModel method uses a linear combination of model spectra 
(characteristic spectra of every metabolite of interest) to 
fit a given measured spectrum, instead of fitting individual 
resonance peaks from specific chemical groups. Since 
the spectra of most metabolites usually contain more than 
one peak, in theory, this method should be able to sepa-
rate contributions of metabolites whose spectra severely 
overlap in some region(s), but do not overlap so much 
in other region(s). The method also has model terms to 
describe the baseline, which mainly results from lipid and 
macromolecule resonances. In the present study, a basis 
set containing 87 model spectra from metabolites, lipids 
and macromolecules was used. However, for long echo 
times (i.e., lasting more than 100 ms), as in the present 
case, LCModel only fits the spectral region between 1.0 
and 4.0 ppm, excluding spectra that fall outside this region. 
Therefore, only 14 metabolite and 9 lipid/macromolecule 
spectra were used in our spectral fittings.
In all cases, only metabolites that were quantified by 
LCModel with Cramer-Rao bounds (13) smaller than 30% 
were considered.
Figure 1 shows an example spectrum averaged over 
subjects. Figure 1a shows the measured spectrum (black 
line) and respective LCModel fit (red line), and Figure 1b 
shows the corresponding residue.
Results
As mentioned earlier, two types of analyses were per-
formed with the present data: one consisting of separate 
quantification of each subject’s spectra followed by averag-
ing the quantification results over subjects (quantification 
prior to estimation of mean value), and the other consisting 
of averaging spectra over subjects followed by quantifica-
tion of the mean spectrum (quantification after estimation 
of mean value). The quantification prior to estimation of 
mean value provided spectra with a very low signal-to-noise 
ratio, which resulted in changes that did not correlate with 
the paradigm and that were surpassed by error bars (data 
not shown). 
With the quantification after estimation of mean values, 
NAAG was reliably quantified separately. Figure 1c and d 
show separate NAA and NAAG fits, respectively, for the 
Figure 1. Example of averaged-over-subjects spectrum. a, Measured spectrum (black line) and LCModel fit (red line). b, Correspond-
ing residue. c, Individual N-acetyl-aspartate (NAA) fit for the spectrum in a. d, Individual N-acetyl-aspartyl-glutamate (NAAG) fit for the 
spectrum in a.
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averaged-over-subjects spectrum of Figure 1a. Figure 2 
shows plots for the relative variations of NAA, NAAG, and 
NAA+NAAG concentrations along the paradigm. From these 
plots, we see that these metabolites follow a variation pattern 
along the paradigm that is larger than the error bars. This 
was thus the only type of analysis that allowed assessing 
metabolic variations associated with the stimulus.
For all phantom acquisitions, none of the quantified 
metabolites varied by more than 2% along the acquisition, 
attesting the stability of the scan during the experiments. 
Discussion
The results associated with NAA and NAAG are re-
markable, given that for these metabolites the variations 
associated with the stimulus are much larger than the 
error bars. NAA and NAAG are usually quantified as a 
group due to the large overlap of their spectra. However, 
as mentioned, LCModel has been successfully used to 
separate the contributions of these metabolites in “static” 
MRS experiments (3,6,7). In the plots shown in Figure 2, we 
see that NAA decreased by about 20% with the stimulus, 
while NAAG concomitantly increased by about 200%. On 
the other hand, the NAA+NAAG plot shows that the sum of 
these metabolites changed by about 3%, which is around 
the percent variations found for phantom fluctuations, i.e., 
the sum of these metabolites virtually did not change. 
Such variations fall into models for the energy metabolism 
underlying neuronal activation, that point to NAAG as 
being responsible for the hyperemic vascular response 
that causes the BOLD signal (4,14). They also agree with 
the fact that NAAG and NAA are present in the brain at a 
ratio of about 1:10, and with the fact that the only known 
metabolic pathway for NAAG synthesis is from NAA and 
glutamate (4). These results are also in line with the fact 
that NAA has been shown to participate in the neuronal 
energy metabolism (1), and NAAG is known to mediate 
neurotransmissions (2).
To the best of our knowledge, there are only two other 
literature reports that point to a similar result. Both studies 
used visual stimuli and paradigms similar to ours. Sarchielli 
et al. (10) found a decrease in NAA levels during visual 
stimulation for three groups of subjects: 22 patients with 
migraine with aura, 22 patients with migraine without aura, 
and 10 healthy subjects. The decrease was more marked 
for the first group (14.6% for the patients with migraine with 
aura). Based on this, the authors suggested that there is a 
smaller efficiency of the mitochondrial functions for these 
patients, given that NAA is an indicator of the functional 
integrity of the neuronal mitochondrial metabolism (2). 
Baslow et al. (11) found a similar decrease in NAA lev-
els at the end of stimulation for healthy subjects (13.1%). 
They proposed that the NAA decrease was due to the fact 
that this metabolite works as a water pump, expelling into 
the extracellular fluid the water created in the neuron due 
to glucose metabolism. This glucose metabolism would 
be caused by neuronal activation resulting from visual 
stimulation. This explanation has been contested, given 
that up to now no protein has been found that would act to 
Figure 2. Changes of N-acetyl-L-aspartate (NAA), N-acetyl-as-
partyl-glutamate (NAAG) and NAA+NAAG in response to stimu-
lations. Shaded regions correspond to stimulation periods. Error 
bars correspond to propagation of the LCModel quantification 
error.
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transport NAA and water out of the neurons (1). In addition, 
at present there is little knowledge about the propagation 
means that specifically regulate NAA liberation from neu-
rons (1). Therefore, considering the investigations carried 
out so far, NAA does not have the necessary features to 
fulfill the water pump function (1). On the other hand, the 
result obtained by Baslow et al. (11) was challenged by 
Mangia and Tkac (15), who claimed that in their research 
using a similar stimulus and paradigm, but performed 
with a 7 Tesla system (12), they were not able to detect 
any significant NAA variation. They only found significant 
changes of lactate, glutamate, glucose, and aspartate. In 
spite of the differences between the two studies (11,12), 
such as the intensity of the magnetic field, Mangia and Tkac 
(15) stated that this divergence between results should 
not exist. Baslow et al. (16) argued that the way Mangia et 
al. (12) computed their spectral averages would not allow 
detecting NAA variations larger than about 2%. In addition, 
according to the reply of Baslow et al. (16), Mangia et al. 
(12) took it for granted that the NAA signal should remain 
stable (rather than considering it a hypothesis to be veri-
fied) and presented combined data for two different (short 
and long) paradigms (12), while only the long paradigm is 
comparable to the results of Baslow et al. (11).
When we compare our results with those obtained by 
Sarchielli et al. (10), Baslow et al. (11) and Mangia et al. 
(12), we have two possible scenarios. On the one hand, 
our results seem to agree with those of Sarchielli et al. (10) 
and Baslow et al. (11), given that both reported decreases 
in the NAA peak associated with the stimulus, a fact that 
qualitatively corresponds to our result for this metabolite. 
It is important to remember, however, that both studies ef-
fectively measured the combined variation of NAA+NAAG, 
whereas our analysis allowed us to separate the contribu-
tions of these metabolites. On the other hand, if we assume 
that the results reported by Mangia et al. (12) also refer 
to the sum of NAA+NAAG (which is not explicit in their 
report), then our conjugated result for these metabolites is 
consistent with theirs.
In short, we presented here preliminary results of ex-
periments performed using the innovative fMRS technique 
to study possible changes of NAA and NAAG under visual 
stimulation. We compared these results with findings of 
similar studies in the literature and highlighted controversial 
aspects associated with them. In the center of this contro-
versy is the fact that while it is virtually the only method for 
measuring changes in NAA and NAAG in the human brain 
in vivo, the fMRS technique still presents considerable 
technical challenges, such as low sensitivity, which results 
in low spatial and temporal resolution. Thus, the effec-
tive fMRS signal ends up by being the result of averages 
performed on relatively large brain regions, compromising 
the reliability desirable to infer what is happening at the 
molecular level.
In addition, the differentiation process of the NAA and 
NAAG signals is particularly difficult. We know of only 
one study with positive results for the separation of these 
signals at a field strength of 3 Tesla (9). Given that such 
a procedure is fundamental for the analysis of NAA and 
NAAG changes, this will be the next step in our research 
using 1H-fMRS in order to confirm (or refute) the results 
discussed in the present paper.
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